Quantum Biopharma (QNTM) Other Operating Expenses (2019 - 2026)

Quantum Biopharma's Other Operating Expenses history runs 8 years deep, the most recent figure standing at $2.3 million for Q1 2026.

• In Q1 2026, Other Operating Expenses rose 53.36% year-over-year to $2.3 million; the TTM figure through Mar 2026 stood at $3.2 million (up 93.22% YoY), while the FY2025 annual figure was $3.5 million, up 443.15% from the prior year.
• Other Operating Expenses came in at $2.3 million for Q1 2026 at Quantum Biopharma, up from $937823.0 in the prior quarter.
• In the past five years, Other Operating Expenses ranged from a high of $4.8 million in Q1 2023 to a low of $177884.0 in Q4 2024.
• A 5-year average of $2.0 million and a median of $1.5 million in 2025 frame the typical range for Other Operating Expenses.
• Across the five-year window, Other Operating Expenses soared 427.21% in 2025 and soared 53.36% in 2026, its largest moves.
• Quantum Biopharma's Other Operating Expenses stood at $1.2 million in 2022, then jumped by 176.86% to $3.3 million in 2023, then sank by 94.57% to $177884.0 in 2024, then jumped by 427.21% to $937823.0 in 2025, then soared by 143.7% to $2.3 million in 2026.
• According to Business Quant data, Other Operating Expenses over the past three periods registered $2.3 million, $937823.0, and $1.5 million for Q1 2026, Q4 2025, and Q1 2025 respectively.

Peer Comparison